Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-24 · accession 0001808805-21-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-24 | 2021-11-24 | NAUT | Mowry Anna | CFO, Treas | P - Purchase | $4.58 | +15.0K | 32.5K | +86% | +$68.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-24 | P | A | 15,000 | $4.58 | 32,500 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $4.545 to $4.58 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |